Climb Bio (CLYM) announced the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Before joining Climb Bio, Dr. Wilson served as ...
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson ...
马萨诸塞州韦尔斯利希尔斯讯 - 市值1.02亿美元的临床阶段生物科技公司Climb Bio, Inc. (NASDAQ: CLYM )宣布任命Perrin Wilson博士为新任首席商务官。Wilson博士在制药和生物科技行业拥有超过17年的经验,将加入公司管理团队,负责领导商业化前期规划、沟通和业务发展工作。
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果